Company Directory / research
PrivateFor profitresearchSydney, Australia
EnGeneIC
EnGeneIC develops and commercializes the treatment of cancer through the targeted delivery of therapeutic agents directly to cancer cells.
- Founded
- 2000 26 years ago
- Staff
- 11-50 band, as listed
- Followers
- - on LinkedIn
- Funding
- $17M as listed, currency not stated
Set against six million companies
Size
11-50 people: larger than 33% of companies with a size listed
Age
26 years old.
Reach
No web traffic ranking listed.
What it does
BiotechnologyLife ScienceTherapeutics
Funding, as listed
$17M currency not stated
- Rounds5
- LatestSeries unknown, Apr 2017
- Investors2, 1 leading
What the source datasets report. We have not watched these rounds ourselves.
Every detail we hold
Everything the source datasets list about EnGeneIC, field by field. Contact details are held but never shown.
The company
- Name
- EnGeneIC
- Type
- For profit
- Status
- Private
- Founded
- 2000
- Founders
- Himanshu Brahmbhatt, Jennifer A. MacDiarmid
- Industry
- research
- Categories
- Biotechnology, Life Science, Therapeutics
Where
- City
- Sydney
- Country
- Australia
- Markets
- Asia-Pacific (APAC), Australasia
Size and reach
- Staff band
- 11-50
Funding, as listed
- Total
- 16,982,691 (currency not stated)
- Rounds
- 5
- Latest round
- Series unknown
- Latest round date
- Apr 2017
- Investors
- 2
- Lead investors
- 1
- Listing status
- private
About this record
- Sources
- Crunchbase
- Last imported
- Sept 2026
Companies like it
research in Australia.
From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 128,574 companies in Australia and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.